top of page

Clinical Indications
Glioblastoma Multiforme
-
GBM represent 15% of brain tumors
-
3.2 cases per 100,000 population
-
Median Survival Without Treatment-3 Months
-
Median Survival With Treatment-1- 2 years
-
Low quality of life
-
Etiology-Unknown
-
Current Standard of Care– Maximal surgical resection followed by 6 weeks of radiotherapy,
together with concomitant chemotherapy with TMZ. Once chemoradiotherapy is complete, a minimum of 6 months of adjuvant treatment with TMZ is started
-
Approximate Cost to Health Care System~$100 –250K/Year/Patient (Raizer 2014)

bottom of page